Clandestine Drug Manufacturing and Environmental Harm: A Legal and Investigative Perspective
Lead author · Corresponding
Srinivasan Gopal, IRS
Assistant Director (Narcotics) at National Academy of Customs, Indirect Taxes and Narcotics, Palasamudram, India
View PDF
Full text
DOIhttps://doij.org/10.10000/IJLMH.1110522
Abstract
This article explores India’s growing menace of clandestine synthetic drug labs—particularly mephedrone—operated by scientifically trained individuals amid socioeconomic stress and digital anonymity. Drawing on major busts across the country, it reveals operational hubs in idle industrial spaces, links to transnational cartels, and abuse of bail provisions. It calls for industrial policing reforms, highlights environmental damage due to chemical waste, and proposes a multi-agency response that includes narcotics enforcement and regulatory bodies. Tools like UNODC’s CLIP app are spotlighted for enhancing chemical traceability and legal accountability.
Keywords
clandestine lab/factory
mephedrone
CLIP
empty industrial spaces
transnational cartels
hbitual offenders
environmental harm
youth fuelling demand through social media APPs